Compass Pathways (CMPS) Gets Buy Rating from H.C. Wainwright

AI Summary

Compass Pathways (CMPS) received a reiterated Buy rating from H.C. Wainwright. This endorsement indicates the firm's confidence in the company's future prospects. Analysts believe this rating may influence investment decisions and market movements for CMPS. Continued support from such firms is often seen as a positive signal for potential investors.